Myeloid-specific Mll4 knockout mice showed an almost complete block of NASH, while hepatocyte-specific Mll4 knockout mice showed mild inhibition of steatosis. This evidence concerns the gene KMT2D and metabolic dysfunction-associated steatohepatitis.